Chison Medical Technologies Stock Return On Asset
| 688358 Stock | 26.51 0.24 0.91% |
Chison Medical Technologies fundamentals help investors to digest information that contributes to Chison Medical's financial success or failures. It also enables traders to predict the movement of Chison Stock. The fundamental analysis module provides a way to measure Chison Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chison Medical stock.
Chison | Return On Asset |
Chison Medical Technologies Company Return On Asset Analysis
Chison Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Chison Total Assets
Total Assets |
|
Based on the latest financial disclosure, Chison Medical Technologies has a Return On Asset of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The return on asset for all China stocks is 100.0% lower than that of the firm.
Chison Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chison Medical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chison Medical could also be used in its relative valuation, which is a method of valuing Chison Medical by comparing valuation metrics of similar companies.Chison Medical is currently under evaluation in return on asset category among its peers.
Chison Fundamentals
| Current Valuation | 1.91 B | ||||
| Price To Book | 2.16 X | ||||
| Price To Sales | 6.55 X | ||||
| Revenue | 483.84 M | ||||
| EBITDA | 125.83 M | ||||
| Net Income | 146.48 M | ||||
| Total Debt | 4.02 M | ||||
| Cash Flow From Operations | 85.91 M | ||||
| Market Capitalization | 3.55 B | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 305.98 M | ||||
| Working Capital | 1.2 B | ||||
| Net Asset | 1.52 B |
About Chison Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chison Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chison Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chison Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Chison Stock
Chison Medical financial ratios help investors to determine whether Chison Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chison with respect to the benefits of owning Chison Medical security.